THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
47 hedge funds and large institutions have $403M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
Holders
47
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.56M | |
| 3 | +$1.25M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$701K |
| 5 |
State Street
Boston,
Massachusetts
|
+$644K |
Top Sellers
| 1 | -$3.82M | |
| 2 | -$606K | |
| 3 | -$293K | |
| 4 |
D.E. Shaw & Co
New York
|
-$281K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$200K |